Ligand-Based Structural Hypotheses for Virtual Screening

Journal of Medicinal Chemistry

Volumn 47, Issue 4, 2004, Pages 947-961

  Jain, Ajay N ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

4 AMINOBUTYRIC ACID A RECEPTOR; HISTAMINE RECEPTOR; LIGAND; MUSCARINIC RECEPTOR; PROTEIN; SEROTONIN RECEPTOR;

ARTICLE; BINDING SITE; CONFORMATION; DRUG DESIGN; DRUG SCREENING; DRUG TARGETING; LIGAND BINDING; MOLECULAR MODEL; QUANTITATIVE STRUCTURE ACTIVITY RELATION; SURFLEX SIMILARITY MODULE;

ALGORITHMS; BINDING SITES; LIGANDS; MODELS, MOLECULAR; MOLECULAR CONFORMATION; MOLECULAR STRUCTURE; PROTEINS; QUANTITATIVE STRUCTURE-ACTIVITY RELATIONSHIP; RECEPTORS, G-PROTEIN-COUPLED; RECEPTORS, GABA-A;

EID: 0842325913     PISSN: 00222623     EISSN: None     Source Type: Journal    
DOI: 10.1021/jm030520f     Document Type: Article

References (31)

1. Walters, P. W.; Stahl, M. T.; Murcko, M. A. Virtual Screening - An Overview. Drug Discovery Today 1998, 3, 160-178.
2. Renfrey, S.; Featherstone, J. Structural proteomics. Nat. Rev. Drug Discovery 2002, 1, 175-176.
3. Cramer, R. D.; Patterson, D. E.; Bunce, J. D. Comparative Molecular Field Analysis (CoMFA). Effect of Shape on Binding of Steroid to Carrier Proteins. J. Am. Chem. Soc. 1988, 110, 5959-5967.
4. Martin, Y. C.; Bures, M. G.; Danaher, E. A.; DeLazzer, J.; Lico, I.; Pavlik, P. A. A fast new approach to pharmacophore mapping and its application to dopaminergic and benzodiazepine agonists. J. Comput.-Aided Mol. Des. 1993, 7, 83-102.
5. Willett, P. Searching for pharmacophoric patterns in databases of three-dimensional chemical structures. J. Mol. Recognit. 1995, 8, 290-303.
6. Clark, D. E.; Westhead, D. R.; Sykes, R. A.; Murray, C. W. Active-site-directed 3D database searching: pharmacophore extraction and validation of hits. J. Comput.-Aided Mol. Des. 1996, 10, 397-416.
7. Jain, A. N.; Dietterich, T. G.; Lathrop, R. H.; Chapman, D.; Critchlow, R. E., Jr.; Bauer, B. E.; Webster, T. A.; Lozano-Perez, T. A shape-based machine learning tool for drug design. J. Comput.-Aided Mol. Des. 1994, 8, 635-652.
8. Jain, A. N.; Koile, K.; Chapman, D. Compass: predicting biological activities from molecular surface properties. Performance comparisons on a steroid benchmark. J. Med. Chem. 1994, 37, 2315-2327.
9. Jain, A. N.; Harris, N. L.; Park, J. Y. Quantitative binding site model generation: compass applied to multiple chemotypes targeting the 5-HT1A receptor. J. Med. Chem. 1995, 38, 1295-1308.
10. Jain, A. N. Surflex: fully automatic flexible molecular docking using a molecular similarity-based search engine. J. Med. Chem. 2003, 46, 499-511.
11. Bissantz, C.; Folkers, G.; Rognan, D. Protein-based virtual screening of chemical databases. 1. Evaluation of different docking/scoring combinations. J. Med. Chem. 2000, 43, 4759-4767.
12. McGovern, S. L.; Shoichet, B. K. Information decay in molecular docking screens against holo, apo, and modeled conformations of enzymes. J. Med. Chem. 2003, 46, 2895-2907.
13. Hindle, S. A.; Rarey, M.; Buning, C.; Lengauer, T. Flexible docking under pharmacophore type constraints. J. Comput.-Aided Mol. Des. 2002, 16, 129-149.
14. Lemmen, C.; Lengauer, T. Computational methods for the structural alignment of molecules. J. Comput.-Aided Mol. Des. 2000, 14, 215-232.
15. Jain, A. N. Morphological similarity: a 3D molecular similarity method correlated with protein-ligand recognition. J. Comput.-Aided Mol. Des. 2000, 14, 199-213.
16. Lin, C. H.; Haadsma-Svensson, S. R.; Lahti, R. A.; McCall, R. B.; Piercey, M. F.; Schreur, P. J.; Von Voigtlander, P. F.; Smith, M. W.; Chidester, C. G. Centrally acting serotonergic and dopaminergic agents. 1. Synthesis and structure-activity relationships of 2, 3, 3a, 4, 5, 9b-hexahydro-1H-benz[e]indole derivatives. J. Med. Chem. 1993, 36, 1053-1068.
17. Lin, C. H.; Haadsma-Svensson, S. R.; Phillips, G.; Lahti, R. A.; McCall, R. B.; Piercey, M. F.; Schreur, P. J.; Von Voigtlander, P. F.; Smith, M. W.; Chidester, C. G. Centrally acting serotonergic and dopaminergic agents. 2. Synthesis and structure-activity relationships of 2, 3, 3a, 4, 9, 9a-hexahydro-1H-benz[f]-indole derivatives. J. Med. Chem. 1993, 36, 1069-1083.
18. Nilvebrant, L. Tolterodine and its active 5-hydroxymethyl metabolite: pure muscarinic receptor antagonists. Pharmacol. Toxicol. 2002, 90, 260-267.
19. Nordvall, G.; Sundquist, S.; Johansson, G.; Glas, G.; Nilvebrant, L.; Hacksell, U. 3-(2-Benzofuranyl)quinuclidin-2-ene derivatives: novel muscarinic antagonists. J. Med. Chem. 1996, 39, 3269-3277.
20. Johansson, G.; Sundquist, S.; Nordvall, G.; Nilsson, B. M.; Brisander, M.; Nilvebrant, L.; Hacksell, U. Antimuscarinic 3-(2-furanyl)quinuclidin-2-ene derivatives: synthesis and structure-activity relationships. J. Med. Chem. 1997, 40, 3804-3819.
21. O'Neil, M. J.; Smith, A.; Patricia, E. H.; Obenchain, J. R.; Gallipeau, J. A. R.; D'Arecca, M. A. Merck Index: An Encyclopedia of Chemicals, Drugs, & Biologicals, 13th ed.; Merck & Co.: Rahway, NJ, 2001.
22. Horn, F.; Weare, J.; Beukers, M. W.; Horsch, S.; Bairoch, A.; Chen, W.; Edvardsen, O.; Campagne, F.; Vriend, G. GPCRDB: an information system for G protein-coupled receptors. Nucleic Acids Res. 1998, 26, 275-279.
23. Feher, M.; Schmidt, J. M. Multiple flexible alignment with SEAL: a study of molecules acting on the colchicine binding site. J. Chem. Inf. Comput. Sci. 2000, 40, 495-502.
24. Miller, M. D.; Sheridan, R. P.; Kearsley, S. K. SQ: a program for rapidly producing pharmacophorically relevant molecular superpositions. J. Med. Chem. 1999, 42, 1505-1514.
25. Willett, P. Similarity and Clustering in Chemical Information Systems; Research Studies Press: Letchworth, 1987.
26. Davies, M.; Newell, J. G.; Derry, J. M.; Martin, I. L.; Dunn, S. M. Characterization of the interaction of zopiclone with γ-aminobutyric acid type A receptors. Mol. Pharmacol 2000, 58, 756-762.
27. McKernan, R. M.; Farrar, S.; Collins, I.; Emms, F.; Asuni, A.; Quirk, K. ; Broughton, H. Photoaffinity labeling of the benzodiazepine binding site of α1β3γ2 γ-aminobutyric acid A receptors with flunitrazepam identifies a subset of ligands that interact directly with His102 of the alpha subunit and predicts orientation of these within the benzodiazepine pharmacophore. Mol. Pharmacol 1998, 54, 33-43.
28. Huang, Q.; He, X.; Ma, C.; Liu, R.; Yu, S.; Dayer, C. A.; Wenger, G. R.; McKernan, R.; Cook, J. M. Pharmacophore/receptor models for GABA(A)/BzR subtypes (α1β3γ2, α5β3γ2, and α6β3γ2) via a comprehensive ligand-mapping approach. J. Med. Chem. 2000, 43, 71-95.
29. Kramer, A.; Horn, H. W.; Rice, J. E. Fast 3D molecular superposition and similarity search in databases of flexible molecules. J. Comput.-Aided Mol. Des. 2003, 17, 13-38.
30. Perkins, E.; Sun, D.; Nguyen, A.; Tulac, S.; Francesco, M.; Tavana, H.; Nguyen, H.; Tugendreich, S.; Barthmaier, P.; Couto, J.; Yeh, E.; Thode, S.; Jarnagin, K.; Jain, A. N.; Morgans, D.; Melese, T. Novel inhibitors of poly(ADP-ribose) polymerase/PARP1 and PARP2 identified using a cell-based screen in yeast. Cancer Res. 2001, 61, 4175-4183.
31. Hardman, J. G.; Limbird, L. E.; Gilman, A. G. Goodman and Gilman's: The Pharmacological Basis of Therapeutics, 10th ed.; The McGraw-Hill Companies, Inc.: New York, 2001.